SEC Form 4 · accession 0001209191-18-021166
Arcadia Biosciences, Inc. · RKDA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sarah Reiter
Officer — Chief Commercial Officer
Period of report
Mar 19, 2018
Accepted (ET)
Mar 21, 2018 · 7:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001469443
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $45.69 | Mar 19, 2018 | A | 10,000 | A | Mar 19, 2019 | Mar 19, 2028 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The option vests with respect to 25% of the total securities subject to the option on the first anniversary of the date of award, or March 19, 2019, with the remaining 75% vesting in 36 equal installments beginning March 31, 2019 and ending February 28, 2022, subject to the Participant's continued service.